PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAmryt Pharma
Amryt Pharma(AMYT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Annual sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
LojuxtaLomitapide2013-07-312025-2027
Hypercholesterolemia
MyaleptaMetreleptin2018-07-29
Lipodystrophy
,
Familial partial lipodystrophy
MycapssaOctreotide2022-12-022029-2040
Pancreatic neoplasms
,
Diarrhea
,
Pituitary neoplasms
,
Adenoma
,
Acromegaly
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Metreleptin
type 1 diabetes mellitus
,
obesity
,
overweight
,
body weight
,
non-alcoholic fatty liver disease
,
fatty liver
,
metabolic syndrome
,
liver diseases
,
weight loss
,
hiv infections
,
syndrome
,
fasting
,
amenorrhea
,
lipoma
,
multiple symmetrical lipomatosis
,
lipomatosis
,
weight gain
,
depression
,
anorexia nervosa
,
diabetes mellitus
,
familial partial lipodystrophy
,
hypertriglyceridemia
,
insulin resistance
,
morbid obesity
,
hyperlipidemias
,
lipodystrophy
,
congenital generalized lipodystrophy
,
hiv-associated lipodystrophy syndrome
Lomitapide
hyperlipoproteinemia type ii
,
homozygous familial hypercholesterolemia
,
pregnancy
,
hypercholesterolemia
Nepidermin
glioblastoma
,
glioma
,
hypertension
,
pulmonary hypertension
,
pulmonary arterial hypertension
,
heart failure
,
pulmonary edema
,
lymphoma
,
squamous cell carcinoma
,
squamous cell neoplasms
,
prostatic neoplasms
,
peritoneal neoplasms
,
breast neoplasms
,
hiv infections
,
infections
,
ovarian neoplasms
,
acquired immunodeficiency syndrome
,
neoplasms
,
communicable diseases
,
neoplasm metastasis
,
melanoma
,
anemia
,
premature obstetric labor
,
nasal polyps
,
ovarian epithelial carcinoma
,
overactive urinary bladder
,
non-small-cell lung carcinoma
,
chronic renal insufficiency
,
kidney diseases
,
thrombocytopenic purpura idiopathic
,
thrombocytopenic purpura
,
purpura
,
vomiting
,
nausea
,
head and neck neoplasms
,
renal cell carcinoma
,
lung neoplasms
,
urinary tract infections
,
recurrence
,
non-hodgkin lymphoma
,
fallopian tube neoplasms
,
endometrial neoplasms
,
erectile dysfunction
,
gonorrhea
,
muscle spasticity
,
urinary incontinence
,
enuresis
,
postmenopausal osteoporosis
,
stomach neoplasms
,
gastrointestinal neoplasms
,
acute coronary syndrome
,
syndrome
,
parkinson disease
,
respiratory tract diseases
,
orthomyxoviridae infections
,
human influenza
,
sarcoma
,
carcinoma
,
brain neoplasms
,
small cell lung carcinoma
,
thrombosis
,
venous thrombosis
,
thrombophlebitis
,
polyps
,
rhinosinusitis
,
herpes simplex
,
postoperative nausea and vomiting
,
post-traumatic stress disorders
,
traumatic stress disorders
,
whooping cough
,
tetanus
,
diphtheria
,
triple negative breast neoplasms
,
mucinous adenocarcinoma
,
ductal carcinoma breast
,
inflammatory breast neoplasms
,
immunologic deficiency syndromes
,
atherosclerosis
,
onychomycosis
,
covid-19
,
systemic lupus erythematosus
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
exanthema
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use